Global /China /Healthcare /Drug Manufacturers - General /000952

Hubei Guangji Pharmaceutical Co., Ltd.

000952

• SHE: 000952 • Delayed

7.39CNY 1.7%

1.09 USD

As of 16 June 2026, Hubei Guangji Pharmaceutical Co., Ltd. has a market cap of $378.65M USD, ranking #17060 globally and #5312 in China. It ranks #1547 in the Healthcare sector, and #558 in the Drug Manufacturers - General industry.

Global Rank

17060

Country Rank

5312

Sector Rank

1547

Industry Rank

558

Key Stats

Market Cap

$378.65MUSD

2.56B CNY

Enterprise Value

$508.73MUSD

3.44B CNY

Revenue (TTM)

$94.36MUSD

638.58M CNY

EBITDA (TTM)

$8.13MUSD

55.03M CNY

Net Income (TTM)

-$59.09MUSD

-399.87M CNY

EBITDA Margin

8.6%

Profit Margin

-63%

PS Ratio

4.0

PB Ratio

4.3

EV/EBITDA

56.4

Company Profile

Country (HQ)

China

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Cheng Gong open_in_new

Employees

1,398

Founded

1969

Website

guangjipharm.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
1.7%	13%	2.9%	-8.3%	10%	5.8%	39%	0.1%	1.4%

News

Markets

Exchange	Ticker	Price	Quotes
Shenzhen Stock Exchange (SHE / SZSE) MIC: XSHE PRIMARY	000952 湖北广济药业股份有限公司 Class A ISIN: CNE0000010R5 Shares Out.: Shares Outstanding: 344.0M¹ Shares Float: 242.952M² TV: TradingView: SZSE: 000952 SA: Stock Analysis: SHE: 000952 YF: Yahoo Finance: 000952.SZ GF: Google Finance: SHE: 000952 BA: Barron's: 000952 MS: Morningstar: XSHE: 000952	7.39 CNY	TV: TradingView: SZSE: 000952 SA: Stock Analysis: SHE: 000952 YF: Yahoo Finance: 000952.SZ GF: Google Finance: SHE: 000952 BA: Barron's: 000952 MS: Morningstar: XSHE: 000952

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Hubei Guangji Pharmaceutical Co., Ltd.

Hubei Guangji Pharmaceutical Co., Ltd. manufactures and sells pharmaceutical raw materials, pharmaceutical preparations, and feed additives in China and internationally. It also exports its products. The company was founded in 1969 and is based in Wuxue, China.

Similar Companies

Industry: Drug Manufacturers - General (China)

Name	Market Cap (USD) diff.	PE	Country
Jiangsu Hengrui Pharmaceuticals Co.,Ltd SSE: 600276	$53.92B 364.89B CNY 14K%	44.9	China
WuXi AppTec Co., Ltd. SSE: 603259	$49.7B 336.36B CNY 13K%	17.2	China
Hansoh Pharmaceutical Group Company Ltd. SHEK: 3692	$28.52B 223.48B HKD 7K%	35.7	China
Innovent Biologics, Inc. SHEK: 1801	$18.8B 147.32B HKD 5K%	162.3	China
Sichuan Biokin Pharmaceutical Co.,Ltd. SSE: 688506	$16.53B 111.89B CNY 4K%	-	China
Akeso, Inc. SHEK: 9926	$16.01B 125.46B HKD 4K%	-	China

Industry: Drug Manufacturers - General (Global)

Name	Market Cap (USD) diff.	PE	Country
Eli Lilly and Co. NYSE: LLY	$761.68B 201K%	38.1	United States
Johnson & Johnson NYSE: JNJ	$547.28B 144K%	26.4	United States
AbbVie Inc. NYSE: ABBV	$360.63B 95K%	97.4	United States
Roche Holding AG SIX: RO	$320.51B 256.25B CHF 85K%	19.9	Switzerland
AstraZeneca PLC LSE: AZN	$288.14B 215.59B GBP 76K%	27.6	United Kingdom
Merck & Co., Inc. NYSE: MRK	$274.03B 72K%	15.1	United States

chevron_leftBack